We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$650M
AUM Growth
+$19.6M
(+3.1%)
Cap. Flow
-$8.55M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
59.87%
Holding
259
New
44
Increased
68
Reduced
78
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$61.6M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$59.4M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$3.59M |
| 4 |
Verizon
VZ
|
+$2.51M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$57.8M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$55.8M |
| 3 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$10.3M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$6.5M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$6.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.57% |
| 2 | Healthcare | 4.98% |
| 3 | Industrials | 2.9% |
| 4 | Real Estate | 2.39% |
| 5 | Financials | 2.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
TSMC
TSM
$2.18T
| – | – |
-30,288
| Closed | -$606K |
|
252
Westlake Corp
WLK
$9.87B
| – | – |
-29,771
| Closed | -$1.97M |
|
|
DRE
253
DELISTED
Duke Realty Corp.
DRE
| – | – |
-30,000
| Closed | -$506K |
|
|
DFT
254
DELISTED
DuPont Fabros Technology Inc.
DFT
| – | – |
-13,445
| Closed | -$324K |
|
|
EQY
255
DELISTED
Equity One
EQY
| – | – |
-11,000
| Closed | -$246K |
|
|
RSE
256
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| – | – |
-10,000
| Closed | -$172K |
|
|
XLS
257
DELISTED
EXELIS INC COM STK
XLS
| – | – |
-107,466
| Closed | -$1.91M |
|
|
AVIV
258
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
| – | – |
-18,000
| Closed | -$440K |
|
|
OREX
259
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – |
-19,800
| Closed | -$1.29M |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q2 2014 Portfolio in Review
As of Q2 2014, Bailard held 259 positions worth $650M, up 3.1% from $630M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Bailard's Q2 2014 filing shows 44 new, 68 increased, 78 reduced and 25 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,301,222 shares worth $65.1M. The largest sale was iShares US Real Estate ETF, an estimated $57.8M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 5.7% a quarter earlier, followed by Healthcare and Industrials.
- Bailard's largest Q2 2014 buy was State Street Energy Select Sector SPDR ETF: 1,301,222 shares worth $65.1M.
- Bailard added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $59.4M increase.
- Bailard's biggest Q2 2014 reduction was iShares US Real Estate ETF, cutting an estimated $57.8M.
- Bailard fully exited Arbutus Biopharma in Q2 2014, selling an estimated $2.05M.
- Bailard's ten largest holdings make up 60% of its $650M portfolio in Q2 2014.
- Bailard opened 44 new positions and closed 25 in Q2 2014.
- Bailard's portfolio value rose 3.1% quarter-over-quarter to $650M.
Based on Bailard's 13F filing for Q2 2014, filed 30 Jul 2014.